Christopher M. Jewell, Chief Scientific Officer at Cartesian Therapeutics, Inc. (RNAC), sold 68,180 shares at $16.34 ($1.1M) on 2024-11-14, disclosed to the SEC on 2024-11-18.
Open-market sale of $1.1M RNAC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.34 | 18,550 | $303K | 26.4% |
| 2 | $17.02 | 17,500 | $298K | 25.9% |
| 3 | $17.06 | 16,065 | $274K | 23.9% |
| 4 | $17.06 | 16,065 | $274K | 23.9% |
| Total | $16.85 avg | 68,180 | $1.1M | 100% |